Mass Drug Administration for Malaria: A Means to What end?

J Infect Dis. 2016 Dec 15;214(12):1790-1792. doi: 10.1093/infdis/jiw484.

Authors

Ingrid Chen¹, Roly Gosling¹, Chris Drakeley², Teun Bousema^{2

3}

Affiliations

¹ Malaria Elimination Initiative, Global Health Group, University of California-San Francisco.
² Department of Immunology and Infection, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, United Kingdom.
³ Department of Medical Microbiology, Radboud University Nijmegen Medical Center, The Netherlands.

PMID: 27923945
DOI: 10.1093/infdis/jiw484

No abstract available

Keywords: Zambia; dihydroartemisinin-piperaquine; elimination; falciparum.

Publication types

Editorial
Comment

MeSH terms

Antimalarials
Artemisinins*
Drug Therapy, Combination
Humans
Malaria, Falciparum
Mass Drug Administration*
Quinolines

Substances

Antimalarials
Artemisinins
Quinolines